All AbMole products are for research use only, cannot be used for human consumption.
Aloperine is an isolated alkaloid in sophora plants such as Sophora alopecuroides L, which exhibits anti-inflammatory, antibacterial, antiviral, and anti-tumor properties. Aloperine treatment potently inhibits the swelling of the rat's hind paw induced by injecting carrageenin, macostatin, PGE2, histamine, or 5-HT, suppresses the rat's scald oedema induced by scalding its hind paw, and blocks the increased permeability of capillaries caused by histamine and the leukocytic migratory response. Aloperine treatment greatly improves the 2, 4-dinitrofluorobenzene (DNFB)-induced allergic contact dermatitis in BALB/c mice, which might be related to the reduction of TNF-alpha, IL-1beta and IL-6 production induced by DNFB. Aloperine exerts the most potent in vitro cytotoxic activity against the human cancer cell lines, compared with other Sophora flavescens Ait. (SF) derived quinolizidine alkaloids including sophoridine, sophocarpine, matrine, oxymatrine and cytisine. Aloperine treatment also significantly inhibits dermatitis index and ear thickness in DNFB-treated NC/Nga mice in a dose-dependent manner. Eosinophils, mast cells infiltration into the ears and plasma level of immunoglobulin (Ig) E are also suppressed by Aloperine treatment. Topical application of Aloperine increases the immunosuppressive cytokine IL-10 level, while it reduces other cytokines production in a dose-dependent manner. Clinically, Aloperine has been widely used in China for decades to treat patients with allergic contact dermatitis, eczema and other skin inflammation.
| Molecular Weight | 232.36 |
| Formula | C15H24N2 |
| CAS Number | 56293-29-9 |
| Form | Solid |
| Solubility (25°C) | DMSO |
| Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
| Related Apoptosis Products |
|---|
| Coenzyme Q0
Coenzyme Q0 (CoQ0) is a potent, oral active ubiquinone compound. Coenzyme Q0 induces apoptosis and autophagy, suppresses of HER-2/AKT/mTOR signaling to potentiate the apoptosis and autophagy mechanisms. Coenzyme Q0 regulates NFκB/AP-1 activation and enhances Nrf2 stabilization in attenuation of inflammation and redox imbalance. |
| C6 Ceramide
C6 Ceramide (C6-Cer) is a short-chain, cell-permeable ceramide pathway activator with anticancer activity. C6 Ceramide-mediated miR-29b expression participates in the progression of multiple myeloma through suppressing the proliferation, migration and angiogenesis of endothelial cells by targeting Akt signal pathway. |
| DB2115 tertahydrochloride
DB2115 tertahydrochloride is a potent inhibitor of myeloid master regulator PU.1. DB2115 tertahydrochloride has the potential for researching cancers, including hematologic cancers. |
| 14-3-3η Protein inhibitor 1
14-3-3η Protein inhibitor 1 is a 14-3-3η protein inhibitor with a KD of 35 µM. |
| Deferoxamine
Deferoxamine (Deferoxamine B) is an iron chelator (binds to Fe(III) and many other metal cations), is widely used to reduce iron accumulation and deposition in tissues. Deferoxamine upregulates HIF-1α levels with good antioxidant activity. Deferoxamine also shows anti-proliferative activity, can induce apoptosis and autophagy in cancer cells. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
